Agios Pharmaceuticals
AGIO
#5097
Rank
A$2.57 B
Marketcap
A$43.04
Share price
-3.10%
Change (1 day)
25.04%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: A$2.57 Billion

As of November 2026 Agios Pharmaceuticals has a market cap of A$2.57 Billion. This makes Agios Pharmaceuticals the world's 5097th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.57 B5.53%
2025A$2.43 B-20.34%
2024A$3.06 B67.62%
2023A$1.82 B-19.42%
2022A$2.26 B-7.92%
2021A$2.46 B-36.91%
2020A$3.90 B-16.34%
2019A$4.66 B22.42%
2018A$3.81 B6.73%
2017A$3.57 B46.78%
2016A$2.43 B-27.6%
2015A$3.35 B-33.86%
2014A$5.07 B506.25%
2013A$0.83 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

A$2.57 Billion
by Nasdaq info icon info icon
A$2.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$234.92 B 9,025.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.801 T 69,866.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$143.45 B 5,472.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
A$3.81 B 48.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$24.04 B 833.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.80 B 591.62%๐Ÿ‡บ๐Ÿ‡ธ USA